ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) accounts for 15–20% of all BC cases and is characterized by HER2 overexpression, aggressive tumor growth, and poor prognosis (Slamon et al. 1989).